Cost-effectiveness of omalizumab in adults with severe asthma: results from the Asthma Policy Model.
Wu AC, Paltiel AD, Kuntz KM, Weiss ST, Fuhlbrigge AL. Cost-effectiveness of omalizumab in adults with severe asthma: results from the Asthma Policy Model. J Allergy Clin Immunol. 2007 Nov; 120(5):1146-52.